Heather Parsons

25PUBLICATIONS
227CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 19, 2026
Paxalisib with Trastuzumab for HER2-Positive Metastatic Breast Cancer with Active Brain Metastases: A Phase II Trial with Integrated Plasma and CSF ctDNA Analyses.

|Jul 16, 2026
Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

|Jul 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

|Mar 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Mar 04, 2026
A glucocorticoid-FAS axis controls immune evasion during metastatic seeding.

Monica Cassandras, Xavier Sanchez, Lauren Hsu

|Sep 15, 2025
Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes.

Mona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger

Pageof 5

Frequent Collaborators

10 joint publications

Sara M Tolaney

5 joint publications

Viktor A Adalsteinsson

5 joint publications

Daniel G Stover

4 joint publications

Filipa Lynce